comparison of acyclovir and bleomycin injection in treatment of warts

Not yet recruiting

• Conditions: Viral wart, unspecified,

• Registration Number: CTRI/2022/07/044451
• Lead Sponsor: Military hospital

Brief Summary

Warts are the manifestations of human papillomavirus (HPV) infection. Intralesional bleomycin hasbeen used for the treatment of warts since the 1970s with high efficacy even atlow concentration. It is proven to be effective with resolution rates of more than 90%. Injection acyclovir is a newer treatment modality reported to be effective in treatment of warts. Thus, we plan to conduct a randomized, controlled trial in order toevaluate the safety and efficacy of intralesional injection acyclovir in comparison to intralesional injection bleomycin.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-08
• Last Update Posted: 2022-07-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients aged 18-60 years with clinical diagnosis of warts.

Exclusion Criteria

• 1.Patients below the age of 18 years and above the age of 60 years.
• 2.Patients not willing to participate in the study.
• 3.Pregnant or lactating females.
• Patients with any systemic illness 5.
• Patient with history of treatment of warts in last 6 months 7.Patients having hypersensitivity to bleomycin or acyclovir.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
clinical resolution of warts	clinical resolution of warts at 24 weeks

Secondary Outcome Measures

Name	Time	Method
patient satisfaction score	at presentation and 6 months after treatment

Trial Locations

Locations (1)

Military Hospital jammu; 🇮🇳 JAMMU, & KASHMIR, India

Military Hospital jammu

🇮🇳JAMMU, & KASHMIR, India

Dr eeshaan ranjan

Principal investigator

8383058229

eeshaan.ranjan@gmail.com